Paul J. Clancy, Executive VP and CFO at BIOGEN IDEC INC. (BIIB), sold 21,400 shares at $120.00 ($2.6M) on 2012-02-01, disclosed to the SEC on 2012-02-03.
Scheduled sale ($2.6M) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.00 | 8,400 | $1.0M | 39.3% |
| 2 | $120.00 | 13,000 | $1.6M | 60.7% |
| Total | $120.00 avg | 21,400 | $2.6M | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |